ICCM vs. SKIN, CATX, OM, TLSI, MGRM, SI, INGN, STIM, NNOX, and INFU
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Beauty Health (SKIN), Perspective Therapeutics (CATX), Outset Medical (OM), TriSalus Life Sciences (TLSI), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), Neuronetics (STIM), Nano-X Imaging (NNOX), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.
IceCure Medical vs. Its Competitors
IceCure Medical (NASDAQ:ICCM) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.
Beauty Health has a net margin of -6.13% compared to IceCure Medical's net margin of -317.62%. Beauty Health's return on equity of -32.82% beat IceCure Medical's return on equity.
IceCure Medical has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500.
In the previous week, Beauty Health had 8 more articles in the media than IceCure Medical. MarketBeat recorded 15 mentions for Beauty Health and 7 mentions for IceCure Medical. Beauty Health's average media sentiment score of 0.96 beat IceCure Medical's score of 0.30 indicating that Beauty Health is being referred to more favorably in the news media.
IceCure Medical has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
IceCure Medical presently has a consensus target price of $2.39, suggesting a potential upside of 141.89%. Beauty Health has a consensus target price of $2.63, suggesting a potential upside of 4.79%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe IceCure Medical is more favorable than Beauty Health.
0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Beauty Health beats IceCure Medical on 9 of the 17 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICCM) was last updated on 9/12/2025 by MarketBeat.com Staff
Free ICCM Stock Alerts